Literature DB >> 12722872

Aplidin increases sensitivity to treatment in leukemia and lymphoma cells.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12722872

Source DB:  PubMed          Journal:  Expert Rev Anticancer Ther        ISSN： 1473-7140            Impact factor:   4.512


× No keyword cloud information.
  1 in total

1.  Multicenter phase II study of plitidepsin in patients with relapsed/refractory non-Hodgkin's lymphoma.

Authors:  Vincent Ribrag; Dolores Caballero; Christophe Fermé; Emanuele Zucca; Reyes Arranz; Javier Briones; Christian Gisselbrecht; Gilles Salles; Alessandro M Gianni; Henry Gomez; Carmen Kahatt; Claudia Corrado; Sergio Szyldergemajn; Sonia Extremera; Bernardo de Miguel; Martin Cullell-Young; Franco Cavalli
Journal:  Haematologica       Date:  2012-10-12       Impact factor: 9.941
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.